loading...

REM Sleep Behavior Disorder Screening Questionnaire (RBDSQ)

Stiasny-Kolster K; Schäfer S; Möller JC; Heinzel-Gutenbrunner M; Mayer G; Oertel W

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

Published in 2007

Authors

Stiasny-Kolster K; Schäfer S; Möller JC; Heinzel-Gutenbrunner M; Mayer G; Oertel W

Copyright
RBDSQ © 2007 International Parkinson and Movement Disorder Society (MDS). All Rights Reserved
Objective
To facilitate the diagnosis and recruitment of patients with REM Sleep Behavior Disorder
Therapeutic area
  • Nervous System Diseases
  • Pathological Conditions, Signs and Symptoms
Therapeutic indication
  • Sleep Disorders (includes apnea)
  • Generic for Nervous System Diseases
Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • German for Germany
Bibliographic reference(s) of the original questionnaire

Stiasny-Kolster K, Mayer G, Schäfer S, Möller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument. Mov Disord. 2007 Dec;22(16):2386-93 (PubMed Abstract)

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use

Authors

Stiasny-Kolster K; Schäfer S; Möller JC; Heinzel-Gutenbrunner M; Mayer G; Oertel W

Dr Karin Stiasny-Kolster
E-mail: stiasny-kolster@schlaflabor-marburg.de

Copyright Holder: The International Parkinson and Movement Disorders Society (MDS)
Contact: Shazia Ali
E-mail: sali@movementdisorders.org

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Students, physicians, clinical practice, not-funded academic users

You may access available translations of the questionnaire directly (see tutorial). Should you not see the Download button, please contact us.

Funded academic users, healthcare organizations, commercial users & IT companies

Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • German for Germany

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

RBDSQ

Arabic for Israel*
English for Australia*
English for Canada*
English for the UK*
English for the USA*
Finnish for Finland*
French for Canada*
French for France*
German for Austria*
Greek for Greece
Hebrew for Israel*
Indonesian for Indonesia*
Italian for Italy*
Japanese for Japan*
Malay for Singapore*
Mandarin for Singapore*
Mandarin for Taiwan*
Norwegian for Norway*
Portuguese for Portugal*
Russian for Israel*
Spanish for Spain*
Spanish for the USA*
Swedish for Sweden*
Tamil for Singapore*
* Performed by Mapi

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

More information on translations

For information on, or permission to use the translations, please contact:  Mapi Research Trust

Bibliographic reference of the Korean translation:

Lee SA, Paek JH, Han SH, Ryu HU. The utility of a Korean version of the REM sleep behavior disorder screening questionnaire in patients with obstructive sleep apnea. J Neurol Sci. 2015 Nov 15;358(1-2):328-32 (PubMed abstract)

Bibliographic references of the Japanese translation:

Nomura T, Inoue Y, Kagimura T, Kusumi M, Nakashima K. Validity of the Japanese version of the REM Sleep Behavior Disorder (RBD) Screening Questionnaire for detecting probable RBD in the general population. Psychiatry Clin Neurosci. 2015 Aug;69(8):477-82 (Full text article)

Nihei Y, Takahashi K, Koto A, Mihara B, Morita Y, Isozumi K, Ohta K, Muramatsu K, Gotoh J, Yamaguchi K, Tomita Y, Sato H, Seki M, Iwasawa S, Suzuki N. REM sleep behavior disorder in Japanese patients with Parkinson's disease: a multicenter study using the REM sleep behavior disorder screening questionnaire. J Neurol. 2012 Aug;259(8):1606-12 (PubMed abstract)

Miyamoto T, Miyamoto M, Iwanami M, Kobayashi M, Nakamura M, Inoue Y, Ando C, Hirata K. The REM sleep behavior disorder screening questionnaire: validation study of a Japanese version. Sleep Med. 2009 Dec;10(10):1151-4 (PubMed abstract)

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us